Arecor Therapeutics plc (AIM:AREC)
41.00
-1.00 (-2.38%)
May 13, 2025, 4:35 PM GMT+1
Arecor Therapeutics Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -10.24 | -8.55 | -9.26 | -6.17 | -2.75 | Upgrade
|
Depreciation & Amortization | 0.44 | 0.49 | 0.34 | 0.17 | 0.17 | Upgrade
|
Other Amortization | 0.01 | 0.01 | 0 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | 3.29 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 0.16 | 0.64 | 0.5 | 0.48 | 0.32 | Upgrade
|
Other Operating Activities | -0.28 | 0.69 | -0.71 | 0.48 | -0.34 | Upgrade
|
Change in Accounts Receivable | -0.63 | -1 | -0.05 | -1.26 | 0.38 | Upgrade
|
Change in Inventory | 0.29 | 0.36 | 0.59 | - | - | Upgrade
|
Change in Accounts Payable | -1.83 | 1.38 | -2.2 | 0.84 | 0.36 | Upgrade
|
Change in Other Net Operating Assets | -0.35 | 0.16 | - | - | - | Upgrade
|
Operating Cash Flow | -9.16 | -5.84 | -10.78 | -5.45 | -1.86 | Upgrade
|
Capital Expenditures | -0.02 | -0.15 | -0.3 | -0.07 | -0.05 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | Upgrade
|
Cash Acquisitions | - | - | 0.28 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -0.05 | - | - | Upgrade
|
Investment in Securities | 1.64 | 6.38 | -8.04 | - | - | Upgrade
|
Other Investing Activities | 0.1 | 0.28 | 0.11 | 0 | 0 | Upgrade
|
Investing Cash Flow | 1.72 | 6.52 | -7.99 | -0.07 | -0.05 | Upgrade
|
Long-Term Debt Issued | 0.01 | 0.04 | - | 2.5 | 1.91 | Upgrade
|
Short-Term Debt Repaid | - | - | -0.3 | - | - | Upgrade
|
Long-Term Debt Repaid | -0.12 | -0.2 | -0.17 | -0.11 | -0.05 | Upgrade
|
Total Debt Repaid | -0.12 | -0.2 | -0.46 | -0.11 | -0.05 | Upgrade
|
Net Debt Issued (Repaid) | -0.11 | -0.17 | -0.46 | 2.39 | 1.86 | Upgrade
|
Issuance of Common Stock | 6.42 | - | 6 | 20 | - | Upgrade
|
Other Financing Activities | -0.66 | -0.02 | -0.38 | -1.46 | -0.08 | Upgrade
|
Financing Cash Flow | 5.65 | -0.18 | 5.16 | 20.93 | 1.77 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.07 | -0.17 | 0.06 | 0.01 | -0.04 | Upgrade
|
Net Cash Flow | -1.85 | 0.33 | -13.55 | 15.42 | -0.18 | Upgrade
|
Free Cash Flow | -9.18 | -5.99 | -11.08 | -5.52 | -1.91 | Upgrade
|
Free Cash Flow Margin | -181.63% | -131.03% | -461.05% | -476.60% | -112.43% | Upgrade
|
Free Cash Flow Per Share | -0.27 | -0.20 | -0.38 | -0.24 | -0.12 | Upgrade
|
Cash Interest Paid | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | Upgrade
|
Cash Income Tax Paid | - | -1.29 | -0.73 | -0.76 | -0.3 | Upgrade
|
Levered Free Cash Flow | -6.52 | -3 | -7.06 | -3.6 | -1.48 | Upgrade
|
Unlevered Free Cash Flow | -6.51 | -2.99 | -7.05 | -3.59 | -1.43 | Upgrade
|
Change in Net Working Capital | 2.46 | -1.76 | 1.09 | 0.44 | -0.28 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.